Astemizole (marketed under the brand name Hismanal) is a second generation antihistamine drug which has a long duration of action. It has been withdrawn from the market in most countries because of rare but potentially fatal interactions with CYP34A enzyme inhibitors.
Astemizole competitively binds to histamine H1-receptor sites in the gastrointestinal tract, uterus, blood vessels, and bronchial muscle. This suppresses the formation of edema and pruritus (caused by histamine).
More on [ Astemizole ]
Hismanal Withdrawn - Federal Register Aug. 22, 1999 relating to the withdrawal of Hismanal (astemizole) 10mg tablets from the US market (PDF)
| The 13-metal medal - Periodic Table of Videos | |
| Next Video | |